3933.HK Overview

Company Profile

Related stocks

HCM.L • Hong Kong SAR China

HUTCHMED (CHINA) LIMITED ORD US

203 GBp

2.33B USD 1Y -11.8%

HCM • Hong Kong SAR China

HUTCHMED (China) Limited

14.1 USD

2.45B USD 1Y -16.6%

RGC • Hong Kong SAR China

Regencell Bioscience Holdings L

7.35 USD

3.64B USD 1Y -60.7%

0512.HK • Hong Kong SAR China

GRAND PHARMA

4.74 HKD

2.12B USD 1Y -43.5%

2005.HK • Hong Kong SAR China

SSY GROUP

2.67 HKD

975.57M USD 1Y -10.6%

4540.T • Japan

TSUMURA & CO

3,772 JPY

1.78B USD 1Y +5%

600216.SS • China

ZHEJIANG MEDICINE

12.59 CNY

1.81B USD 1Y -12.9%

600267.SS • China

ZHEJIANG HISUN PHARMACEUTICAL C

11.94 CNY

2.11B USD 1Y +13.5%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile

4 Metrics

Country

Hong Kong SAR China

Region

Asia-Pacific

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High

5Y Volatility

46.4% p.a.

Max Drawdown (5Y)

-57.8%

Sharpe Ratio (5Y)

0.11

Beta Factor

0.30

Size Class

Large Cap

Notes & Warnings

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (46.4% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -66.2% in the extended horizon.